NCT06499584

Brief Summary

In humans, surface electrophysiological recordings of the cochlear nerve in response to a sound stimulus provide information about the cochlear's ability to encode sound. Depending on the stimulus, the fine structure and temporal envelope of the signal will vary, allowing us to determine its characteristics. By phenotyping patients before surgery using subjective and objective audiometric tests, it will be possible to isolate for each patient the moment when the fine structure disappears and when the temporal envelope is effective.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
18mo left

Started Mar 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress69%
Mar 2023Dec 2027

Study Start

First participant enrolled

March 21, 2023

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

June 6, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

July 12, 2024

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Last Updated

July 12, 2024

Status Verified

June 1, 2024

Enrollment Period

3.7 years

First QC Date

June 6, 2024

Last Update Submit

July 11, 2024

Conditions

Keywords

Hearing LossDeafnessMicro vascular decompressionOtoneurosurgeryRetrosigmoid approach

Outcome Measures

Primary Outcomes (2)

  • To compare the amplitude of coding of complex and ecological sounds

    The goal is to compare the amplitude of coding of complex and ecological sounds (logatomes in the form of vowels or syllables: association of a consonant and a vowel) in the human auditory nerve between patients defined as normo and poorly hearing according to preoperative audiometric tests.

    At 48 months

  • To compare the spectrum of coding of complex and ecological sounds

    The goal is to compare the spectrum of coding of complex and ecological sounds (logatomes in the form of vowels or syllables: association of a consonant and a vowel) in the human auditory nerve between patients defined as normo and poorly hearing according to preoperative audiometric tests.

    At 48 months

Secondary Outcomes (4)

  • The spectrum of the temporal envelope of the signal

    At 48 months

  • The amplitude of the temporal envelope of the

    at 48 months

  • The spectrum of the fine structure of the signal

    at 48 months

  • The amplitude of the fine structure of the signal

    at 48 months

Study Arms (2)

normal hearing patients

EXPERIMENTAL

free of sensorineural hearing loss, defined by mean hearing thresholds of less than or equal to 20 dB HL in air conduction pure tone audiometry, bilaterally on the side of the operated ear and on the non-operated side at 0.5, 1, 2 and 4 kHz.

Procedure: near field recording of human auditory nerve activity during retro sigmoid approach with contact electrode

hearing impaired patients

EXPERIMENTAL

with sensorineural hearing loss defined by average hearing thresholds between 21 dB HL and 40 dB HL at 0.5, 1, 2 and 4 kHz.

Procedure: near field recording of human auditory nerve activity during retro sigmoid approach with contact electrode

Interventions

During surgery using a retro-sigmoid approach in the cerebellopontine angle (microvascular decompression), near-field recording of human auditory nerve activity using a contact electrode is performed on patients with normal or impaired hearing threshold. Each patient is explored preoperatively by hearing tests. During the surgery, stimuli are delivered.

hearing impaired patientsnormal hearing patients

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The following will be included as hearing-impaired patients:
  • Male or female
  • Over 18 and up to 80 years of age
  • Normal otoscopic examination
  • Scheduled for surgery on the cerebellopontine angle (microvascular decompression)
  • With sensorineural hearing loss defined by average hearing thresholds between 21 dB HL and 40 dB HL at 0.5, 1, 2 and 4 kHz
  • Affiliated to a social security scheme
  • Having read the information note describing the study and having agreed in writing to participate by signing the informed consent form
  • Will be included as normal-hearing patients:
  • Male or female
  • Over 18 and up to 80 years of age
  • Normal otoscopic examination
  • Scheduled for surgery on the cerebellopontine angle (microvascular decompression)
  • Free of sensorineural hearing loss, defined by average hearing thresholds of less than or equal to 20 dB HL in tonal air conduction audiometry, bilaterally on the side of the ear undergoing surgery and on the side not undergoing surgery, at 0.5, 1, 2 and 4 kHz
  • Affiliated to a social security scheme
  • +1 more criteria

You may not qualify if:

  • Notably because of complete tumor invasion of the cochlear nerve (stage III and IV neuroma, advanced meningioma) ;
  • Or because of a particular anatomical feature not identified during the preoperative examination, making its exposure for recordings impossible (protrusion of the posterior face of the rock).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Damien JOLLY

Reims, France

RECRUITING

MeSH Terms

Conditions

Hearing LossDeafness

Condition Hierarchy (Ancestors)

Hearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 6, 2024

First Posted

July 12, 2024

Study Start

March 21, 2023

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2027

Last Updated

July 12, 2024

Record last verified: 2024-06

Locations